About
Our mission is to make a positive contribution to humanity. We aim to improve the lives of people around the world by ensuring everyone has access to safe, effective, and affordable high-quality medicine — so they may live healthier days with their loved ones.
Products
We believe health is for everyone. We are building a pathway to help as many people as possible get access to safe, effective, and affordable high-quality medicine. Our products continue the fight against deadly diseases such as neutropenia and breast cancer.
News & Media
- Press Releases
- Media Resources
Take a look at how we are impacting the world. Our news is your news as we continue our daily efforts to grant more patients access to safe, effective, and affordable high-quality medicine.
Resources
- Brand to Biosimilar Database
We aim to be a respected partner to our customers. We are proud to offer comprehensive patient support services designed to help simplify and support patient access — for every Tanvex product. And, as a service to the healthcare professionals we serve, Tanvex provides a live brand to biosimilar database for product reference purposes.
Careers
Come join our team. We are always looking for bright, motivated employees that share our vision to create a world where everyone has access to safe, effective, and affordable biopharmaceuticals.
Contact
- GET IN TOUCH
Reach out to us. We are ready to listen and help.

Tanvex Reaches Settlement and License Agreement with Genentech

Feb 9, 2023

Tanvex announced that the company has reached an agreement with Genentech to settle the patent litigation related to certain patents associated with Herceptin^®. The legal action, which is pending in the U.S. District Court for the Southern District of California, will be dismissed as a result of the settlement. In addition to the United States, the licensed territory includes the other markets in which Genentech has obtained rights to the respective patents. All other terms of the agreement are confidential.

About Tanvex

Tanvex BioPharma, Inc. (TWSE: 6541) is a biopharmaceutical company focused on the biopharmaceutical market. The Company is vertically integrated with end-to-end inhouse development, manufacturing and commercialization capabilities. Tanvex BioPharma, Inc. is registered in Cayman Islands and has operations and facilities in Irvine, CA, San Diego, CA, and Taipei, Taiwan. Tanvex is publicly traded on the Taiwan Stock Exchange.

BACK TO ALL NEWS